Elysium Health has published new research in Frontiers in Aging demonstrating that its flagship NAD+-boosting supplement — Basis — significantly reduced the frequency and severity of disruptive menopausal symptoms, including hot flashes, bloating, and poor sleep, in women over age 35 who self-reported symptoms associated with the menopause transition. The research also showed a beneficial increase in the ratio of estradiol to estrone, two key forms of estrogen, and characterized a previously unreported NAD+ metabolite that expands scientific understanding of how NAD+ precursors are metabolized in humans.
The open-label pilot study in Frontiers in Aging enrolled 40 healthy women, 32 of whom experienced menopausal symptoms and eight who did not. After seven days of Basis supplementation, the symptomatic group reported reductions of 50% or more in several of the most bothersome symptoms.
Image Credit: Elysium Health